View our list of available Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) antibodies, recombinant proteins, ELISA Kits... Options Full Datasheet Printer Friendly Datasheet Prepare for Printing Full Datasheet Printer Friendly Datasheet Prepare for Printing Have Questions? Ask Us! Add To Compare List Hemagglutinin-Influenza A Virus H3N2 New York 55/04 Recombinant Protein Catalog # MBS142727 Unit / Price DISCONTINUEDClick here to view our similar product(s) OR click here to contact our technical support team for suitable replacement. Product Name Product Info Accession #s Product Desc Diseases/Tissues/Pathways Applications References Product Name Hemagglutinin-Influenza A Virus H3N2 New York 55/04, Recombinant Protein Full Product Name Recombinant Hemagglutinin-Influenza A Virus H3N2 New York 55/04 Product Synonym Names H3N2 New-York; H3N2 Influenza-A Virus New York/55/04 Recombinant; New York 55/04 Research Use Only For Research Use Only. Not for use in diagnostic procedures. TOP Host Baculovirus Insect Cells Purity/Purification Greater than 90.0% as determined by SDS-PAGE. Form/Format The Recombinant H3N2 A/New-York/55/04 solution contains 10mM Sodium phosphate, pH 7.2 and 150mM NaCl.Sterile Filtered colorless solution. Preparation and Storage H3N2 A/New-York/55/04 Recombinant should be stored at 4 degree C. Other Notes Small volumes of Hemagglutinin-Influenza A Virus H3N2 New York 55/04 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply. TOP Related Product Information for Hemagglutinin-Influenza A Virus H3N2 New York 55/04 recombinant protein Description: Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 70,000 dalton.Introduction: H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Product Categories/Family for Hemagglutinin-Influenza A Virus H3N2 New York 55/04 recombinant protein Viral Antigens; INFLUENZA VIRUS; Viral Antigens; Influenza Applications Tested/Suitable for Hemagglutinin-Influenza A Virus H3N2 New York 55/04 recombinant protein Western Blot (WB), ELISA (EIA) Application Notes for Hemagglutinin-Influenza A Virus H3N2 New York 55/04 recombinant protein Immunological Activity: Western-Blot 0.1 ug -1 ug per strip, ELISA 1 ug/Well. TOP Precautions All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines. Disclaimer While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information. TOP